07.11.2015 Views

dgppn kongress

4vyclxbzJ

4vyclxbzJ

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SPECIAL SESSIONS 280<br />

SPECIAL SESSIONS<br />

wed, 25 nov 2015<br />

13.30 – 15.00 h | Room M6<br />

Trauma and migration – Refugees and asylum seekers in mental health care<br />

Vorsitz: Meryam Schouler-Ocak, Berlin (Germany)<br />

Dinesh Bhugra, London (United Kingdom)<br />

› Section: Intercultural Psychiatry and Psychotherapy, Migration<br />

› in cooperation with the DTGPP – German-turkish association for Psychiatry, Psychotherapy<br />

and psychosocial health<br />

› in cooperation with the WPA – World Psychiatric Association<br />

Trauma- and stressor related disorders in refugees and asylum seekers<br />

Dinesh Bhugra, London (United Kingdom)<br />

Cross-cultural Communication with traumatised refugees and asylum seekers<br />

Marianne C. Kastrup, Frederiksberg (Denmark)<br />

Cultural competence in trauma<br />

Adil Qureshi, Barcelona (Spain)<br />

Irene Falgas<br />

Trauma in Kobani and Ezidii refugees in Turkey and gender roles in their community<br />

as risk and resilience factor<br />

Hamid Boztas, Gölköy / Bolu (Turkey)<br />

thu, 26 nov 2015<br />

10.15 – 11.45 h | Hall A4<br />

Breakthroughs in Psychiatry: Are there innovations in the pharmacotherapy<br />

of Schizophrenia foreseeable? State of the art and new directions<br />

Chairs: Moritz Rossner, Munich (Germany)<br />

Peter Falkai, Munich (Germany)<br />

Pharmacotherapy of negative symptoms and dyscognition in schizophrenia:<br />

state of the art<br />

W. Wolfgang Fleischhacker, Innsbruck (Austria)<br />

Autophagy and microtubules as future treatment targets for schizophrenia:<br />

Activity-dependent neuroprotective protein as a case study<br />

Illana Gozes, Tel Aviv (Israel)<br />

The path from genetic findings to prioritized target assessment efforts at Roche –<br />

providing clinical perspectives for the future<br />

Enrico Domenici, Basel (Switzerland)<br />

Identification of Spironolactone in a Repurposing screen for Neuregulin-ERBB4<br />

modulators<br />

Moritz Rossner, Munich (Germany)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!